{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-088326","form_type":"8-K","ticker":"IBIO","cik":"0001420720","company_name":"iBio, Inc.","filed_at":"2023-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.874573+00:00","generated_at":"2026-06-12T04:01:49.557240+00:00","sec_items":["1.01","2.02","3.03"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"medium","headline":"iBio preliminary FY2023 net loss $29-29.5M; cash drops to $7.6M; warrants repriced to $0.50","bullets":["Preliminary FY2023 net loss from continuing ops expected $29.0M-$29.5M vs $29.6M prior year.","Cash at June 30, 2023: $7.6M (incl $3.3M restricted) down from $28.7M (incl $6M) year ago.","Common shares outstanding increased to ~22.4M from 8.7M year ago.","Term note principal balance reduced to ~$13.1M from $22.4M.","Amended exercise price of Series A and B warrants (covering ~5.5M shares) to $0.50 from $1.04."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-088326","json":"https://secwatch.observer/filing/0001104659-23-088326.json","markdown":"https://secwatch.observer/filing/0001104659-23-088326.md","text":"https://secwatch.observer/filing/0001104659-23-088326.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1420720/000110465923088326/0001104659-23-088326-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1420720/000110465923088326/tm2322961d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T04:01:49.557240+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3701913d8ea0a5f2902e2e71a2dd4d946cac10c5","claim":"iBio, Inc. reported twelve months ending June 30, 2023 results: net income net loss from continuing operations ... to be between $29.0 million and $29.5 million.","evidence_excerpt":"On a preliminary unaudited basis, the Company expects net loss from continuing operations for the twelve months ending June 30, 2023, to be between $29.0 million and $29.5 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1420720/000110465923088326/0001104659-23-088326-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"twelve months ending June 30, 2023"},{"label":"Net income","value":"net loss from continuing operations ... to be between $29.0 million and $29.5 million"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}